nobel prize glp 1 Joel Habener Receives Breakthrough in Life Sciences for Contributions to GLP-1 Medications Nobel Prize in medicine: Research

In a recent study, 44% of people on Wegovy reported feeling more tired than usual

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.

Patients with type 2 diabetes who are prescribed liraglutide have a 179% higher likelihood of developing non-arteritic anterior ischemic optic neuropathy (NAION), while those prescribed insulin have an 86% greater likelihood compared to patients who were prescribed other diabetes medications

The rise of GLP-1 medicationssuch as Ozempic and Wegovyis rapidly transforming employer-sponsored health insurance.

LIFT should be usedtwice dailyin the morning and at nightas part of a complete skincare routine